Company intelligence / Profile preview

PU sensor

Linköping, Östergötland County, Swedenjarven.se ↗

Ownership: Private
Development stage: Other

Overview

PU sensor has developed and commercialized a patented research-based medical device that objectively measures microcirculation in the skin to assess an individual's risk of developing pressure ulcers. The technology enables early identification of at-risk patients so that preventive interventions can be implemented before ulcers develop. Clinical use began in Sweden in 2021 and has expanded to Finland, Germany, and Hong Kong. The company’s approach is based on decades of research into pressure ulcer pathophysiology. No clinical trial results are specified.

Therapeutic areas: Dermatology
Modalities: Device (specifically, non-invasive diagnostic device for risk assessment)
Industry: Physiological Monitoring

Beyond the preview

Go deeper on PU sensor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PU sensor.

Explore the full profile